The private sector’s expertise in distribution, innovation and communication are urgently needed to accelerate food fortification in addressing global malnutrition, but there are significant hurdles that need to be overcome.
Australia-based Pharmako Biotechnologies is planning several new studies following the recent announcement of its Therapeutic Goods Administration (TGA)-approved manufacturing site, which allows it to produce pharma grade ingredients for use in clinical...
Bened Biomedical is making inroads into the study of psychobiotics as it embarks on a human clinical trial that looks at its flagship strain Lactobacillus plantarum PS128 on Tourette syndrome and Rett syndrome.
Gencor is venturing into the hair care oral supplement and topical application category, with an RCT studying the benefits of ageratum conyzoides oral supplementation and topical application to take place this year.
BASF has received approval from the Therapeutic Goods Administration (TGA) in Australia to supply a human milk oligosaccharide ingredient, 2’Fucosyllactose (2’-FL), for use as a prebiotic in dietary supplements in Australia.
Malaysian tocotrienol supplier Excelvite is working with supplement brands to promote the use of tocotrienol-rich vitamin E to pharmacists and doctors treating patients with diabetic kidney disease (DKD), on the back of new clinical findings.
The ingredient arm of Thai Union Group is exploring further new product development (NPD) opportunities from tuna as it seeks to expand its functional protein offering by emulating the success of the dairy industry in moving into high-value ingredients.
International Flavors & Fragrances Inc (IFF) and DuPont’s Nutrition & Biosciences (“N&B”) completed their €40.7bn merger yesterday (February 1st) and revealed a modernised identity for the new industry giant.
Interest in the infant nutrition benefits of bifidobacteria is soaring, with a raft of papers published in the last year, and a growing understanding of the impact that human residential strains can have on early-life development.
Japanese health food and dietary supplement firms such as FANCL, Kirin, George & Oliver, Taisho Pharmaceutical, Eminet and Q’sai say its ‘business as usual’ despite certain prefectures coming under a second state of emergency due to the COVID-19 pandemic.
China-based manufacturer Angel Yeast is set to open a new R&D centre in Yichang, Hubei Province this year to accelerate product innovation, with a particular focus on the plant-based sector and sports nutrition.